GNRH1 and central precocious puberty: In South Korea, GnRH stimulation test results are required to diagnose and treat CPP with therapeutics in accordance with a national notification (notification number 2017-180) released by the Ministry of Health and Welfare of Korea regarding the use of GnRH agonists for treatment of CPP [8].